Virginia · 2026 Regular Session · Bill

HB 392: Sickle cell disease education and screening program; cancer risk.

Enacted Last action April 13, 2026: Acts of Assembly Chapter text (CHAP0600)

Plain-language summary

HB 392 is a bill introduced in the Virginia House on January 12, 2026. According to its official title, it concerns: Sickle cell disease education and screening program; cancer risk. Primary sponsor: Alex Askew (Democratic). It lists 78 additional sponsors. Most recent recorded action (April 13, 2026): Acts of Assembly Chapter text (CHAP0600).

Sponsors

Primary sponsor: Alex Askew (Democratic). 78 co-sponsors.